All 1 tracked stories fall under one category: pharma. The Conversation is most often covered alongside CDC, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention The Conversation, all published on March 4, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about The Conversation
All 1 tracked stories fall under one category: pharma. The Conversation is most often covered alongside CDC, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention The Conversation, all published on March 4, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering The Conversation. Shared-story counts are live from our verified record — not editorial picks.
A growing trend of retaining and consuming human tissue, such as placentas and surgical remains, is raising significant biohazard and infection concerns. Medical experts warn that the lack of regulatory oversight and clinical evidence for these practices poses serious risks to public health.
The Conversation is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.